When it comes to putting cash into stocks that you can buy and hold for the long run, and could outperform for years as part of a well-diversified portfolio, here are two top stocks to consider now.
The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson's drug Caplyta as an add-on treatment for adults with major depressive disorder, the company said on Thursday.
Secretin regulates Ca²⁺ signaling in interstitial cells of Cajal in the deep muscular plexus (ICC-DMP), revealing a targeted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback